Fount Bio, founded in 2018 and headquartered in Cambridge, Massachusetts, is a life science company dedicated to advancing skin health through proprietary glycopolymer research. The company's core mission is to revitalize tissues using innovative glycopolymer-based products, leveraging bioorthogonal chemistry to overcome challenges in targeted tissue delivery. Fount Bio's technology platform aims to enhance skin health and potentially extend its applications to other tissue rejuvenation areas.
Notable achievements include winning the prestigious Innovation of the Year award at the 2024 IMCAS. This recognition underscores Fount Bio's impact on the skin health industry and its potential for broader applications. The company's leadership and investors are composed of experts in biotechnology and life sciences, contributing to its rapid growth and innovation. Fount Bio's advancements are poised to make significant contributions to both consumer skincare and medical treatments, positioning it as a leader in tissue rejuvenation technologies.
